Perceptive Advisors LLC 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:25 pm Sale | 2025-06-30 | 13G | Edgewise Therapeutics, Inc. EWTX | Perceptive Advisors LLC | 4,639,949 4.400% | -1,755,597 (-27.45%) | Filing |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Perceptive Advisors LLC | 6,395,546 6.100% | 1,231,059 (+23.84%) | Filing |
| 2025-02-21 5:57 pm Purchase | 2025-02-13 | 13G | Edgewise Therapeutics, Inc. EWTX | Perceptive Advisors LLC | 5,164,487 5.500% | 5,164,487 (New Position) | Filing |